4/A//SEC Filing
Schroeder Martin 4/A
Accession 0001181431-12-016128
CIK 0001425205other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 7:02 PM ET
Size
4.8 KB
Accession
0001181431-12-016128
Insider Transaction Report
Form 4/AAmended
Genesis Biopharma, IncGNBP.OB
Schroeder Martin
Director
Transactions
- Purchase
Common Stock
2011-08-22$0.00/sh+1,000,000$1,000→ 1,000,000 total(indirect: See footnote.)
Footnotes (1)
- [F1]Mr. Schroeder is Executive Vice President and Managing Director of Emmes Group Consulting LLC.
Documents
Issuer
Genesis Biopharma, Inc
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001412295
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 7:02 PM ET
- Size
- 4.8 KB